Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GKB OphthalmicsBOM:533212 +0.10%57 Buyback Yield % is 0.00 as of Aug. 12, 2026. GuruFocus rates BOM:533212 with a GF Score™ of 57/100 and a GF Value™ of ₹163.94 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 344 Medical Devices & Instruments companies, GKB Ophthalmics ranks worse than 290697.38% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for GKB Ophthalmics's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:533212 vs ISRG, BDX, MDLN: Buyback Yield % Comparison
For the Medical Instruments & Supplies subindustry, GKB Ophthalmics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GKB Ophthalmics Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GKB Ophthalmics's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where GKB Ophthalmics's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GKB Ophthalmics (BOM:533212) has a Buyback Yield % of 0.00 as of Aug. 12, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on GKB Ophthalmics and its competitors. According to the industry distribution chart, GKB Ophthalmics ranks #999999 out of 344 companies in the Medical Devices & Instruments industry.
Is GKB Ophthalmics' Buyback Yield % too high?
GKB Ophthalmics' current Buyback Yield % is 0.00. Based on the distribution chart, GKB Ophthalmics ranks #999999 out of 344 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, GKB Ophthalmics has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Buyback Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, GKB Ophthalmics ranks #999999 out of 344 companies for Buyback Yield %. This places GKB Ophthalmics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on GKB Ophthalmics and its competitors. GKB Ophthalmics's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹163.94, compared to a current price of ₹59.99 — trading 63.4% below its estimated fair value. The current Buyback Yield % is 0.00. GKB Ophthalmics' overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Buyback Yield % is 0.00 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?
Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued.
The current stock price of ₹59.99 is trading 63.4% below its estimated GF Value™ of ₹163.94.
GuruFocus considers GKB Ophthalmics to be Significantly Undervalued.
Key valuation signals for BOM:533212:
Buyback Yield %: 0.00
GF Value™: ₹163.94 vs. price of ₹59.99 (63.4% below fair value)
No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
57GF Score
Get the complete analysis for BOM:533212
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:533212 has been successfully added to your 
